These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6667 related articles for article (PubMed ID: 12749752)

  • 41. Role of gangliosides in tumour progression: a molecular target for cancer therapy?
    Fish RG
    Med Hypotheses; 1996 Feb; 46(2):140-4. PubMed ID: 8692038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy.
    Ahmed M; Cheung NK
    FEBS Lett; 2014 Jan; 588(2):288-97. PubMed ID: 24295643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of gangliosides in the interaction of a growth inhibitor with mouse LM cells.
    Bascom CC; Sharifi BG; Melkerson LJ; Rintoul DA; Johnson TC
    J Cell Physiol; 1985 Dec; 125(3):427-35. PubMed ID: 4066767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ganglioside enhancement of neuronal differentiation, plasticity, and repair.
    Gorio A
    CRC Crit Rev Clin Neurobiol; 1986; 2(3):241-96. PubMed ID: 3536311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting of tumor-associated gangliosides with antibodies affects signaling pathways and leads to cell death including apoptosis.
    Horwacik I; Rokita H
    Apoptosis; 2015 May; 20(5):679-88. PubMed ID: 25673107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cancer immunotherapy--current status].
    Kundig TM; Renner Ch; Knuth A
    Ther Umsch; 2006 Apr; 63(4):262-6. PubMed ID: 16689457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-associated CD75s- and iso-CD75s-gangliosides are potential targets for adjuvant therapy in pancreatic cancer.
    Distler U; Souady J; Hülsewig M; Drmić-Hofman I; Haier J; Denz A; Grützmann R; Pilarsky C; Senninger N; Dreisewerd K; Berkenkamp S; Schmidt MA; Peter-Katalinic J; Müthing J
    Mol Cancer Ther; 2008 Aug; 7(8):2464-75. PubMed ID: 18723492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis.
    Yoshida S; Fukumoto S; Kawaguchi H; Sato S; Ueda R; Furukawa K
    Cancer Res; 2001 May; 61(10):4244-52. PubMed ID: 11358851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment.
    van der Haar Àvila I; Windhouwer B; van Vliet SJ
    Cancer Metastasis Rev; 2023 Sep; 42(3):941-958. PubMed ID: 37266839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural analysis of brain ganglioside acetylation patterns in mice with altered ganglioside biosynthesis.
    Mlinac K; Fabris D; Vukelić Z; Rožman M; Heffer M; Bognar SK
    Carbohydr Res; 2013 Dec; 382():1-8. PubMed ID: 24140892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc.
    Oliva JP; Valdés Z; Casacó A; Pimentel G; González J; Alvarez I; Osorio M; Velazco M; Figueroa M; Ortiz R; Escobar X; Orozco M; Cruz J; Franco S; Díaz M; Roque L; Carr A; Vázquez AM; Mateos C; Rubio MC; Pérez R; Fernández LE
    Breast Cancer Res Treat; 2006 Mar; 96(2):115-21. PubMed ID: 16322892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The potential of melanoma antigen expression in cancer therapy.
    Gillespie AM; Coleman RE
    Cancer Treat Rev; 1999 Aug; 25(4):219-27. PubMed ID: 10448130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific immunotherapy of cancer in elderly patients.
    Matzku S; Zöller M
    Drugs Aging; 2001; 18(9):639-64. PubMed ID: 11599633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus.
    Gillard BK; Thomas JW; Nell LJ; Marcus DM
    J Immunol; 1989 Jun; 142(11):3826-32. PubMed ID: 2654294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model.
    Fuentes D; Avellanet J; Garcia A; Iglesias N; Gabri MR; Alonso DF; Vazquez AM; Perez R; Montero E
    Breast Cancer Res Treat; 2010 Apr; 120(2):379-89. PubMed ID: 19377876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunotherapy as an Option for Cancer Treatment.
    Rusch T; Bayry J; Werner J; Shevchenko I; Bazhin AV
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):89-96. PubMed ID: 29026920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody recognition of cancer-related gangliosides and their mimics investigated using in silico site mapping.
    Agostino M; Yuriev E; Ramsland PA
    PLoS One; 2012; 7(4):e35457. PubMed ID: 22536387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human monoclonal antibodies: prospects for the therapy of cancer.
    Wong JH; Irie RF; Morton DL
    Semin Surg Oncol; 1989; 5(6):448-52. PubMed ID: 2556770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoclonal antibodies for the immunotherapy of solid tumours.
    Mauerer R; Gruber R
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1385-98. PubMed ID: 22339220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional roles of gangliosides in neurodevelopment: an overview of recent advances.
    Yu RK; Tsai YT; Ariga T
    Neurochem Res; 2012 Jun; 37(6):1230-44. PubMed ID: 22410735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 334.